Brief news reports on Tuberculosis

Aidspan publishes new issue of ‘Global Fund Observer’

Aidspan: Global Fund Observer

Read More →

Community Advocacy Update: Focus on TB

The December 2018 issue of the Community Advocacy Update highlights the reflections of five advocates on TB activism, including next steps for activists after the UN High-Level Meeting on TB held in September 2018.

Read More →

Webinar: Getting serious about health equity

The O'Neill Institute for National and Global Health Law, CEHURD, and the UCL Institute of Health Equity will host a webinar on 28 January 2019 on health equity.

Read More →

TBpeople hiring: Project Coordinator and Regional Focal Points

TBpeople is looking for Project Coordinator and Regional Focal Points for the project on the development of Declaration on the Rights of People Affected by TB.

Read More →

A new era for global tuberculosis: holding leaders accountable for promises

Read the editorial from The Union leadership, highlighting the next steps for leaders in tuberculosis, which was published in The International Journal of Tuberculosis and Lung Disease:

Read More →

New blood tests for TB could accelerate diagnosis and save the NHS England money

Rapid blood tests used by the National Health Service (NHS) in England are unable to rule out tuberculosis (TB) and should be replaced with a new, more accurate test, a study has found.

Read More →

Sewri TB hospital starts giving bedaquiline to outpatients

In an attempt to prioritise the comfort of patients suffering from tuberculosis, the civic-run TB hospital in Sewri has started giving bedaquiline in the outpatient department (OPD).

Read More →

How we used computers to figure out drugs that can beat drug-resistant TB

Tuberculosis (TB) is one of the leading causes of death from infectious diseases. Globally, it accounts for around 1.3 million deaths and 10.4 million people develop the disease every year.

Read More →

Linezolid does not increase culture conversion rates in TB

Patients with pulmonary tuberculosis who had linezolid added to their treatment regimen for either 2 or 4 weeks did not have higher culture conversion rates compared with individuals who received standard treatment, according to study results published in the Lancet Infectious Diseases.

Read More →

European Laboratory Initiative on TB expands to cover HIV and viral hepatitis

To strengthen and streamline the joint response to tuberculosis (TB), HIV and viral hepatitis in the WHO European Region, the WHO-established European Laboratory Initiative on TB extended its scope to HIV and viral hepatitis. Through this development, WHO aims to address more effectively the specific needs of the Region.

Read More →

Page 1 of 626 · Total posts: 10

1 2 Last→